PCVX insider buying and SEC filings, explained
Vaxcyte, Inc. · CIK 1649094
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$1.0M
Planned sales (10b5-1)
$11.4M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 5, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 18,000 shares at $86.74 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 11% to 145,435 shares. | SEC filing Filed Oct 7, 2026, 4:08 PM ET |
| Oct 5, 2026 | Planned (10b5-1) | Elvia Cowan (SVP, Finance & CAO) sold 19,000 shares at $86.74 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 41% to 27,860 shares. | SEC filing Filed Oct 7, 2026, 4:07 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 2,250 shares at about $56.67 ($128K), marked as a 10b5-1 plan trade. Holdings down 2% to 145,435 shares. | SEC filing Filed Oct 2, 2026, 4:05 PM ET |
| Sep 4–9, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 2,715 shares between Sep 4 and Sep 9 at about $60.35 ($164K), marked as a 10b5-1 plan trade. Holdings down 2% to 145,435 shares. | SEC filing Filed Sep 9, 2026 |
| Sep 1, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 3,477 shares at about $61.08 ($212K), marked as a 10b5-1 plan trade. Holdings down 2% to 155,041 shares. | SEC filing Filed Sep 2, 2026 |
| Aug 5, 2026 | Planned (10b5-1) | Harpreet S. Dhaliwal (Chief Technical Ops Officer) sold 17,000 shares at about $55.00 ($935K), marked as a 10b5-1 plan trade. Holdings down 18% to 76,756 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 2,250 shares at about $53.86 ($121K), marked as a 10b5-1 plan trade. Holdings down 1% to 157,541 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Andrew Guggenhime (CFO) sold 10,000 shares at about $53.89 ($539K), marked as a 10b5-1 plan trade. Holdings down 9% to 105,176 shares. | SEC filing Filed Aug 5, 2026 |
| Jul 27, 2026 | Planned (10b5-1) | Grant Pickering (CEO and Director) sold 18,198 shares directly and indirectly (by trust) at about $55.63 ($1.0M), marked as a 10b5-1 plan trade. Direct holdings down 3% to 453,247 shares. | SEC filing Filed Jul 28, 2026 |
| Jul 6, 2026 | Planned (10b5-1) | Andrew Guggenhime (CFO) sold 10,000 shares at about $57.29 ($573K), marked as a 10b5-1 plan trade. Holdings down 9% to 104,395 shares. | SEC filing Filed Jul 6, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 2,250 shares at about $56.33 ($127K), marked as a 10b5-1 plan trade. Holdings down 1% to 156,760 shares. | SEC filing Filed Jul 6, 2026 |
| Jun 26, 2026 | Planned (10b5-1) | Grant Pickering (CEO and Director) sold 24,237 shares directly and indirectly (by trust) at about $55.22 ($1.3M), marked as a 10b5-1 plan trade. Direct holdings down 5% to 452,466 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 18, 2026 | Planned (10b5-1) | Grant Pickering (CEO and Director) sold 24,461 shares directly and indirectly (by trust) at about $52.50 ($1.3M), marked as a 10b5-1 plan trade. Direct holdings down 5% to 474,703 shares. | SEC filing Filed Jun 18, 2026 |
| Jun 18, 2026 | Planned (10b5-1) | Andrew Guggenhime (CFO) sold 10,000 shares at $53.00 ($530K), marked as a 10b5-1 plan trade. Holdings down 9% to 104,395 shares. | SEC filing Filed Jun 18, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 2,250 shares at about $49.52 ($111K), marked as a 10b5-1 plan trade. Holdings down 1% to 158,494 shares. | SEC filing Filed Jun 3, 2026 |
| May 1, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 2,250 shares at about $56.83 ($128K), marked as a 10b5-1 plan trade. Holdings down 1% to 160,744 shares. | SEC filing Filed May 1, 2026 |
| Apr 7, 2026 | Planned (10b5-1) | Elvia Cowan (SVP, Finance & CAO) sold 3,000 shares at $60.00 ($180K), marked as a 10b5-1 plan trade. Holdings down 9% to 28,975 shares. | SEC filing Filed Apr 8, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 2,250 shares at about $58.43 ($131K), marked as a 10b5-1 plan trade. Holdings down 1% to 162,994 shares. | SEC filing Filed Apr 3, 2026 |
| Mar 17, 2026 | Planned (10b5-1) | Elvia Cowan (SVP, Finance & CAO) sold 1,892 shares at about $55.58 ($105K), marked as a 10b5-1 plan trade. Holdings down 6% to 28,975 shares. | SEC filing Filed Mar 18, 2026 |
| Mar 11, 2026 | Planned (10b5-1) | Elvia Cowan (SVP, Finance & CAO) sold 2,500 shares at $58.59 ($146K), marked as a 10b5-1 plan trade. Holdings down 7% to 30,867 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | Jim Wassil (President / COO) sold 7,395 shares at about $58.88 ($435K), marked as a 10b5-1 plan trade. Holdings down 4% to 166,818 shares. | SEC filing Filed Mar 11, 2026 |
| Dec 31, 2025 | Sale | Harpreet S. Dhaliwal (Chief Technical Ops Officer) sold 9,743 shares at about $46.69 ($455K). Holdings down 29% to 23,928 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 2, 2026 |
| Dec 23, 2025 | Sale | Elvia Cowan (SVP, Finance) sold 11,623 shares at about $47.92 ($557K). Holdings down 44% to 14,534 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 29, 2025 |
47 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PCVX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.